← Mechanisms of action
APP
SINGLE PROTEINHomo sapiens
Preferred name: Beta amyloid A4 protein ChEMBL ↗
Linked proteins
Drugs acting on this target (67)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| ion269 | Antisense inhibitor | experimental | Nucleic acid | APP antisense inhibitor |
| [123i] av-151 | Binding agent | experimental | Small molecule | APP binding agent |
| 123-i mni-187 injection and imaging procedures | Binding agent | experimental | Small molecule | APP binding agent |
| aducanumab (Aduhelm) | Binding agent | approved | mAb | Beta amyloid A4 protein binding agent |
| bapineuzumab | Binding agent | experimental | mAb | Beta amyloid A4 protein binding agent |
| gantenerumab | Binding agent | experimental | mAb | Beta amyloid A4 protein binding agent |
| gsk-933776 | Binding agent | experimental | mAb | Beta amyloid A4 protein binding agent |
| pittsburgh compound b | Binding agent | experimental | Small molecule | APP binding agent |
| ponezumab | Binding agent | experimental | mAb | Beta amyloid A4 protein binding agent |
| solanezumab | Binding agent | experimental | mAb | Beta amyloid A4 protein binding agent |
| contraloid | Degrader | experimental | Small molecule | APP degrader |
| donanemab (Kisunla) | Disrupting agent | approved | mAb | Beta amyloid A4 protein disrupting agent |
| aci-24 | Immunity, active | experimental | Vaccine | APP immunity, active |
| affitope ad06 | Immunity, active | experimental | Vaccine | APP immunity, active |
| an-1792 | Immunity, active | experimental | Peptide | APP immunity, active |
| av-1959 | Immunity, active | experimental | Vaccine | APP immunity, active |
| cad106 | Immunity, active | experimental | Vaccine | APP immunity, active |
| ub-311 | Immunity, active | experimental | Vaccine | APP immunity, active |
| 124i-mu 11-1f4 | Immunity, passive | experimental | mAb | APP immunity, passive |
| pf-05236812 | Immunity, passive | experimental | mAb | APP immunity, passive |
| ponezumab | Immunity, passive | experimental | mAb | APP immunity, passive |
| 11-1f4 | Inhibitor | experimental | mAb | APP inhibitor |
| 124i-p5+14 injection | Inhibitor | experimental | Peptide | APP inhibitor |
| aducanumab (Aduhelm) | Inhibitor | approved | mAb | APP inhibitor |
| as-s603 | Inhibitor | experimental | Small molecule | APP inhibitor |
| at-02 | Inhibitor | experimental | mAb | APP inhibitor |
| bapineuzumab | Inhibitor | experimental | mAb | APP inhibitor |
| bey2153 | Inhibitor | experimental | Small molecule | APP inhibitor |
| cael-101 | Inhibitor | experimental | mAb | APP inhibitor |
| cm383 | Inhibitor | experimental | Small molecule | APP inhibitor |
| crenezumab | Inhibitor | experimental | mAb | APP inhibitor |
| gantenerumab | Inhibitor | experimental | mAb | APP inhibitor |
| gsk-933776 | Inhibitor | experimental | mAb | APP inhibitor |
| gsk2398852 | Inhibitor | experimental | mAb | APP inhibitor |
| homotaurine | Inhibitor | experimental | Small molecule | APP inhibitor |
| jbpos0101 | Inhibitor | experimental | Small molecule | APP inhibitor |
| latrepirdine | Inhibitor | experimental | Small molecule | APP inhibitor |
| LECANEMAB (Leqembi) | Inhibitor | approved | mAb | APP inhibitor |
| ly2599666 | Inhibitor | experimental | mAb | APP inhibitor |
| medi1814 | Inhibitor | experimental | mAb | APP inhibitor |
| mni-330 | Inhibitor | experimental | Small molecule | APP inhibitor |
| neod001 | Inhibitor | experimental | mAb | APP inhibitor |
| ngp 555 | Inhibitor | experimental | Small molecule | APP inhibitor |
| ni006 | Inhibitor | experimental | mAb | APP inhibitor |
| npt088 | Inhibitor | experimental | Small molecule | APP inhibitor |
| p16-129 | Inhibitor | experimental | Small molecule | APP inhibitor |
| ppi-1019 | Inhibitor | experimental | Peptide | APP inhibitor |
| prm-151 | Inhibitor | experimental | Recombinant protein | APP inhibitor |
| prx004 | Inhibitor | experimental | mAb | APP inhibitor |
| Remternetug | Inhibitor | experimental | mAb | APP inhibitor |
| rn6g | Inhibitor | experimental | mAb | APP inhibitor |
| sar228810 | Inhibitor | experimental | mAb | APP inhibitor |
| shr-1707 | Inhibitor | experimental | Small molecule | APP inhibitor |
| solanezumab | Inhibitor | experimental | mAb | APP inhibitor |
| tramiprosate | Inhibitor | experimental | Small molecule | APP inhibitor |
| v950 | Inhibitor | experimental | Small molecule | APP inhibitor |
| vanutide cridificar | Inhibitor | experimental | Biological | APP inhibitor |
| vp 20629 | Inhibitor | experimental | Small molecule | APP inhibitor |
| aducanumab (Aduhelm) | Other | approved | mAb | APP other |
| bapineuzumab | Other | experimental | mAb | APP other |
| gantenerumab | Other | experimental | mAb | APP other |
| gsk-933776 | Other | experimental | mAb | APP other |
| ponezumab | Other | experimental | mAb | APP other |
| solanezumab | Other | experimental | mAb | APP other |
| tramiprosate | Stabiliser | experimental | Small molecule | Beta amyloid A4 protein stabiliser |
| Valiltramiprosate | Stabiliser | experimental | Small molecule | Beta amyloid A4 protein stabiliser |
| vanutide cridificar | Vaccine antigen | experimental | Biological | Beta amyloid A4 protein vaccine antigen |